---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-24-000014"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T14:29:30.904686+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific appoints Jonathan Monson as SVP Investor Relations; Emily Woodworth as CAO

## Summary
- Jonathan Monson appointed SVP Investor Relations effective March 1, 2024; will no longer serve as Chief Accounting Officer.
- Emily Woodworth (Collins) appointed SVP Global Controller and CAO effective March 1, 2024; previously VP Finance and Controller of Urology business.
- Woodworth will receive base salary, annual bonus, and incentive stock awards commensurate with officer level.

## SEC filing metadata
- accession: 0000885725-24-000014
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/0000885725-24-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/bsx-20240126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-24-000014
- JSON: https://secwatch.observer/filing/0000885725-24-000014.json
- Plain text: https://secwatch.observer/filing/0000885725-24-000014.txt

## Key facts
- Executive change
  Emily Woodworth (Collins) was appointed as Senior Vice President, Global Controller and Chief Accounting Officer at BOSTON SCIENTIFIC CORP.
  - Action: appointed
  - Role: Senior Vice President, Global Controller and Chief Accounting Officer
  source text: Also on January 26, 2024, the Board appointed Emily Woodworth (Collins), age 46, as Senior Vice President, Global Controller and Chief Accounting Officer, effective March 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/0000885725-24-000014-index.htm
- Executive change
  Jonathan Monson was appointed as Senior Vice President, Investor Relations at BOSTON SCIENTIFIC CORP.
  - Action: appointed
  - Role: Senior Vice President, Investor Relations
  source text: On January 26, 2024, the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) appointed Jonathan Monson as Senior Vice President, Investor Relations, effective March 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/0000885725-24-000014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.